Japan Intellectual Property Rights: G PROTEIN-COUPLED RECEPTOR (GPCR) MODULATION BY IMIPRIDONES

Japan, March 3 -- ONCOCEUTICS INC has got intellectual property rights for 'G PROTEIN-COUPLED RECEPTOR (GPCR) MODULATION BY IMIPRIDONES.' Other related details are as follows:

Application Number: JP,2021-200772

Category (FI): A61K31/519,A61K39/00@H,A61K39/395@C,A61K39/395@D,A61K39/395@E,A61K39/395@L,A61K39/395@N,A61K39/395@R,A61K39/395@T,A61K45/00,A61K47/55,A61K47/68,A61K51/10,100,A61P1/16,A61P25/18,A61P25/24,A61P31/00,A61P31/04,A61P31/12,A61P31/18,A61P35/00,A61P35/02,A61P37/02,A61P37/04,A61P43/00,107,A61P43/00,111,A61P43/00,121,C07K14/705,C12N5/0783,C12N5/09,C12Q1/6813@Z,G01N33/15@Z,G01N33/50@Z,G01N33/53@D,G01N33/53@M

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Dec. 10, 2021

Publication Date: March 23, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.